Resmed (RMD) FY2024 results: revenue $4.7 billion, up 10.9% on the year
Resmed Inc. (RMD) reported revenue of $4.7 billion for fiscal 2024, the year ended 30 June 2024, up 10.9% on the year before. Net income was $1.0 billion, up 13.7%, and diluted earnings per share $6.92. The figures are the company's own, from the 10-K it filed with the SEC on 9 August 2024.
Revenue
$4.7 billion
+10.9% on the year
FY2017FY2024
Operating margin
28.2%
26.8% a year earlier
FY2017FY2024
Net income
$1.0 billion
+13.7% on the year
FY2017FY2024
Diluted EPS
$6.92
+13.6% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
1,401
693
351
+102.1%
Capital expenditure
99.5
120
135
-16.9%
Free cash flow
1,302
574
216
+126.9%
Free cash flow margin
27.8%
13.6%
6.0%
Cash from investing
-270
-1,160
-230
Cash from financing
-1,119
423
-128
Depreciation and amortisation
177
165
160
+7.1%
Share-based compensation
80.2
71.1
65.3
+12.7%
Buybacks
150
0.0
0.0
Dividends paid
282
258
245
+9.3%
Dividend per share
$1.92
$1.76
$1.68
+9.1%
Diluted shares, weighted
148m
147m
147m
+0.1%
Shares outstanding at period end
147m
147m
146m
-0.1%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
4,864
4,130
3,361
+17.8%
Debt
707
1,441
775
-50.9%
Operating lease liabilities
141
117
120
+21.0%
Other liabilities
1,160
1,064
839
+9.0%
Total liabilities and equity
6,872
6,752
5,096
+1.8%
Fixed assets
548
538
498
+1.9%
Goodwill
2,842
2,770
1,936
+2.6%
Intangible assets
486
552
346
-12.0%
Cash and equivalents
238
228
274
+4.6%
Receivables
837
705
576
+18.8%
Inventory
822
998
744
-17.6%
Other assets
1,099
960
722
+14.4%
Total assets
6,872
6,752
5,096
+1.8%
10-K for the year ended 30 June 2024, filed 9 August 2024: the filing.